ArticleESMO open2024

Clinical relevance of reports on early access programs for checkpoint inhibitors in cancer patients: a French retrospective nationwide cohort study.

A Chatain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.